|
Maolin Guo, associate professor of chemistry and biochemistry at the University of Massachusetts Dartmouth, landed a $400,000 research grant from the National Science Foundation to support the development of a molecular imaging probe for cell research.
more
By PBN Staff
|
|
The Rhode Island College Foundation has landed a $250,000 grant from the Champlin Foundations to help support the renovation of the human anatomy laboratory in the Fogarty Life Science Building.
more
By PBN Staff
|
|
The University of Rhode Island plans to increase its presence in the state’s capital city, according to President David M. Dooley, as part of a strategy to better prepare its students for success as well as help Rhode Island’s economy grow out of the hole it is in.
more
By PBN Staff
|
|
The 2012 meeting of the Greater Providence Chamber of Commerce, held Monday at the R.I. Convention Center, made news that could re-shape the region’s economy.
more
By PBN Staff
|
|
Providence-based EpiVax Inc. was awarded a $55,000 grant from the GBS/CIDP Foundation International to explore using Tregitopes as a new therapy for a nerve disease that is treated currently with intravenous immunoglobulin.
more
By Richard Asinof |
|
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011.
more
By PBN Staff
|
|
The R.I. Economic Development Corporation approved a corporate tax cut Monday night for Alexion Pharmaceuticals under the state’s Jobs Development Act.
more
By Patrick Anderson |
|
During the fiscal year ended June 30, the National Institutes of Health awarded a total of $146.96 million in grants to Rhode Island hospitals, universities and companies.
more
By Emily Greenhalgh |
|
The Norman Prince Neurosciences Institute at Rhode Island Hospital was awarded three philanthropic gifts totaling nearly $600,000 to improve brain science in the state of Rhode Island by supporting research and establishing a lecture series.
more
By Emily Greenhalgh |
|
Medical device maker Covidien PLC’s pharmaceutical arm, Mallinckrodt, has completed its acquisition of St. Paul, Minn.-based CNS Therapeutics Inc. for roughly $100 million.
more
By PBN Staff
|